Data / Research funding / California / Vulcan Biologics, Inc.
Vulcan Biologics, Inc.: 2 NIH awards ($310.9K) and 1 NSF award ($989.9K), fiscal years 2021 to 2026
Vulcan Biologics, Inc. in Irvine, CA is funded under 2 NIH awards ($310.9K) and 1 NSF award ($989.9K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- LNBVDMU2KNN5
- State
- California
Awards
3 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| SBIR Phase II: Bacteriophage-Based Microbial Gene Therapy Platform for In Situ Engineering of Microbiomes | NSF | Start-ups and Small Businesses Section | 2022 | $989,854 | December 15, 2021 | November 30, 2023 | Michael Koeris | nsf.gov |
| SBIR Topic 131: Development of Bacteriophage for Treatment of Mycobacterial Infections | NIH | National Institute of Allergy and Infectious Diseases | 2024 | $299,914 | September 10, 2024 | September 9, 2025 | GREEN, BRIAN | reporter.nih.gov |
| Combining Bacteriophage-Mediated Decolonization with Microbial Engraftment to Foster Sustained Supragingival Microbiome Modulation for Enhanced Anti-Cariogenic Therapy | NIH | National Institute of Dental & Craniofacial Research | 2021 | $10,976 | January 15, 2021 | September 15, 2021 | KOERIS, MICHAEL SANDOR | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 1 | $299,914 | 0 | $0 |
| 2022 | 0 | $0 | 1 | $989,854 |
| 2021 | 1 | $10,976 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Unlocking Dataset Value for AI-Enabled Scientific Discovery (AI Datasets) | 26-512 | NSF | 47.041 | November 4, 2026 | Not listed | Same assistance listing 47.041 as 1 award here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.121 | November 6, 2026 | $350,000 | Same assistance listing 93.121 as 1 award here |
| PFE: Research Initiation in Engineering Formation (PFE: RIEF) | 20-558 | NSF | 47.041 | November 10, 2026 | Not listed | Same assistance listing 47.041 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.121 | November 16, 2026 | $50,000 | Same assistance listing 93.121 as 1 award here |
| National Science Foundation Translation to Practice (NSF TTP) | 25-540 | NSF | 47.041 | November 17, 2026 | $2 million | Same assistance listing 47.041 as 1 award here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.121 | November 17, 2026 | $200,000 | Same assistance listing 93.121 as 1 award here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.121 | November 18, 2026 | Not listed | Same assistance listing 93.121 as 1 award here |
| HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional) | RFA-AT-25-003 | NIH | 93.121 | November 23, 2026 | $375,000 | Same assistance listing 93.121 as 1 award here |
| Maximizing the Scientific Value of Data Generated by the Environmental Influences on Child Health Outcomes (ECHO) Program: Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) | RFA-OD-27-008 | NIH | 93.121 | December 2, 2026 | Not listed | Same assistance listing 93.121 as 1 award here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.121 | December 3, 2026 | Not listed | Same assistance listing 93.121 as 1 award here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.121 | December 4, 2026 | Not listed | Same assistance listing 93.121 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.121 | January 5, 2027 | Not listed | Same assistance listing 93.121 as 1 award here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.121 | January 5, 2027 | Not listed | Same assistance listing 93.121 as 1 award here |
| Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) | PAR-25-098 | NIH | 93.121 | January 7, 2027 | Not listed | Same assistance listing 93.121 as 1 award here |
| Intervention Research to Improve Native American Health (R34 Clinical Trial Optional) | PAR-25-378 | NIH | 93.121 | January 7, 2027 | Not listed | Same assistance listing 93.121 as 1 award here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.121 | January 7, 2027 | Not listed | Same assistance listing 93.121 as 1 award here |
| HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed) | RFA-NS-25-023 | NIH | 93.121 | January 15, 2027 | $350,000 | Same assistance listing 93.121 as 1 award here |
| Training-based Workforce Development for Advanced Cyberinfrastructure | 23-520 | NSF | 47.041 | January 21, 2027 | $1 million | Same assistance listing 47.041 as 1 award here |
| EPSCoR Research Infrastructure Improvement Program: Focused EPSCoR Collaborations (FEC) | 24-573 | NSF | 47.041 | January 26, 2027 | $1.5 million | Same assistance listing 47.041 as 1 award here |
| Biomedical Research Environment and Sponsored Programs Administration Development (BRE-SPAD) Program (UC2- Clinical Trial Not Allowed) | PAR-24-268 | NIH | 93.121 | January 27, 2027 | $500,000 | Same assistance listing 93.121 as 1 award here |
Topics of its NIH awards
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.